Pasithea Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:KTTA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Nov 25	BuyUS$25,000	Tiago Marques	Individual	33,333	US$0.75
28 Nov 25	BuyUS$25,000	Simon Dumesnil	Individual	33,333	US$0.75
28 Nov 25	BuyUS$100,000	Lawrence Steinman	Individual	133,333	US$0.75
12 May 25	SellUS$792	Tiago Marques	Individual	960	US$0.82

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KTTA?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	372,358	1.49%
VC/PE Firms	2,100,000	8.42%
General Public	3,571,985	14.3%
Institutions	6,630,058	26.6%
Hedge Funds	12,265,547	49.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 821.9%.

Top Shareholders

Top 25 shareholders own 85.39% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15%	Coastlands Capital LP	3,735,035	US$3.1m	0%	no data
9.99%	Opaleye Management Inc.	2,491,000	US$2.1m	0%	0.25%
8.42%	Vivo Capital, LLC	2,100,000	US$1.8m	0%	0.12%
8.42%	Adage Capital Management, L.P.	2,100,000	US$1.8m	0%	no data
8.42%	Janus Henderson Group plc	2,100,000	US$1.8m	0%	no data
8.42%	Squadron Capital Management Llc	2,100,000	US$1.8m	0%	0.69%
7.74%	Columbia Management Investment Advisers, LLC	1,930,128	US$1.6m	0%	no data
7.38%	Cable Car Capital LLC	1,839,512	US$1.5m	268%	0.81%
1.8%	Acuta Capital Partners, LLC	450,000	US$378.4k	0%	0.25%
1.45%	Orca Capital GmbH	362,857	US$305.2k	0%	5.43%
1.42%	StemPoint Capital LP	355,082	US$298.6k	0%	0.05%
1.35%	AdvisorShares Investments, LLC	337,508	US$283.8k	10.8%	0.04%
1.17%	Persistent Asset Partners Limited	290,555	US$244.4k	0%	0.09%
1.1%	Stonepine Capital Management LLC	275,062	US$231.3k	0%	0.11%
0.8%	Lawrence Steinman	199,691	US$167.9k	201%	no data
0.57%	Armistice Capital LLC	142,082	US$119.5k	0%	no data
0.39%	The Vanguard Group, Inc.	97,675	US$82.1k	81.5%	no data
0.29%	Tiago Marques	73,334	US$61.7k	83.3%	no data
0.24%	Jane Street Group, LLC	59,372	US$49.9k	137%	no data
0.23%	Citadel Advisors LLC	56,183	US$47.2k	-16.6%	no data
0.22%	Geode Capital Management, LLC	54,495	US$45.8k	114%	no data
0.2%	Two Sigma Investments, LP	48,773	US$41.0k	36.4%	no data
0.14%	Simon Dumesnil	35,833	US$30.1k	1,330%	no data
0.13%	Emer Leahy	33,333	US$28.0k	0%	no data
0.11%	Northern Trust Global Investments	28,090	US$23.6k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/04 16:07
End of Day Share Price	2026/05/01 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pasithea Therapeutics Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sara Nik	H.C. Wainwright & Co.